Anti-epileptic Therapy Not Linked to Increased Dementia Risk, Study Reports
Use of anti-epileptic therapy is not linked to an increased risk of dementia, according to the results of a real-world study with more than ... Read more
Updates
-
-
HIV Therapy May to Help Stop ‘Jumping Gene’ Linked to Inflammation Associated with Aging
HIV therapies that block an enzyme that is essential for viruses to replicate, called reverse transcriptase, may offer a new way of treating age-related ... Read more -
Education Does not Improve Adaptability of Brain in Old Age, Study Suggests
A higher level of education is not related to better cognitive reserve — the ability of the adult brain to maintain normal cognitive function in the presence of ... Read more -
Video Series Informs About the Possible Role of Germs in Alzheimer’s
Addressing fundamental questions about the possibility that Alzheimer’s disease might be brought about by infections, Alzheimer’s Germ Quest has released a series of eight videos, ... Read more
-
Gum Disease Bacteria May Play Role in Alzheimer’s Disease Development, Study Suggests
Porphyomonas gingivalis, a bacteria that causes a type of gum disease known as chronic ... -
Alzheimer’s Association Funds 2-Year Extension of Study that Explores Intensive Blood Pressure Treatment on Dementia Risk
The Alzheimer’s Association has funded a two-year extension of the SPRINT-MIND study — SPRINT MIND 2.0 ... -
Genentech Halts Phase 3 Trials Testing Crenezumab for Early Alzheimer’s Disease
Two Phase 3 trials — CREAD 1 and CREAD 2 — evaluating crenezumab as a ... -
Epigenetic Therapy Restored Memory, Cognitive Function in Mouse Model of Familial AD
Using a new type of approach called epigenetics, researchers were able to temporarily rescue ... -
Anti-epileptic Therapies Linked to Longer Hospital Stays in Alzheimer’s Patients, Study Reports
Alzheimer’s disease patients who take anti-epileptic therapies have a higher number of accumulated days ... -
UB-311 Vaccine Safe, Effective in Mild Alzheimer’s Patients, Phase 2a Trial Suggests
United Neuroscience’s Alzheimer’s vaccine candidate UB-311 was found safe and well-tolerated, triggering an antibody response against beta-amyloid in most ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment
News
Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more